6:14 PM
 | 
May 05, 2010
 |  BC Extra  |  Company News

Savient considering sale

Savient Pharmaceuticals Inc. (NASDAQ:SVNT) said its board determined that a sale of the company following FDA approval of

Read the full 79 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >